Mumbai based IPCA gets a shot in the arm as USFDA suspends import ban for key Covid-19 drug
Posted by
www.biotecnika.org
IPCA has a market share of nearly 70% of these drugs, as it is one of
the largest suppliers of the active pharmaceutical ingredient of these
medicines to several large multinational drug companies. Since the
Covid-19 outbreak the company has supplied nearly 5 lakh tablets
across the world.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/mumbai-based-ipca-gets-a-shot-in-the-arm-as-usfda-suspends-import-ban-for-key-covid-19-drug/articleshow/74768362.cms
Subscribe to:
Post Comments (Atom)
Post a Comment